| David S Harnett, MD | |
|
170 Governors Ave, 1st Floor, Medford, MA 02155-1643 | |
| (781) 306-6160 | |
| (781) 306-6175 |
| Full Name | David S Harnett |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Geriatric Psychiatry |
| Location | 170 Governors Ave, Medford, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417921925 | NPI | - | NPPES |
| C04851 | Other | MA | BLUE CROSS/BLUE SHIELD |
| 0194778 | Medicaid | MA | |
| 002512686130 | Other | MA | OXFORD |
| 260005817 | Other | MA | RAILROAD MEDICARE |
| 700220 | Other | MA | TUFTS/SECURE HORIZONS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0805X | Psychiatry & Neurology - Geriatric Psychiatry | 43765 (Massachusetts) | Primary |
| Entity Name | Pratt Psychiatric Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245270875 PECOS PAC ID: 8921999525 Enrollment ID: O20040323000956 |
News Archive
Noting the United Nations on Wednesday observed the annual International Day of Zero Tolerance for Female Genital Mutilation and Cutting (FGM/C), "an act that is shocking and inhumane to much of the world but remains a tradition among a significant minority," Inter Press Service correspondent Marzieh Goudarzi interviews U.N. Population Fund (UNFPA) Executive Director Babatunde Osotimehin "on UNFPA's role in the global fight against FMG/C."
According to a recent study, led by Virginia Kaklamani, MD, an oncologist at Northwestern Memorial Hospital and assistant professor of medicine, Northwestern University Feinberg School of Medicine, variations of the adiponectin gene, which regulates a number of metabolic processes, may increase a woman's risk of developing breast cancer.
Meanwhile, news outlets report on a range of other implementation issues, including the decision of Ohio Gov. John Kasich to follow through on forming a state-based exchange despite his opposition to the overhaul, changes to FSAs and the measure's impact on farmers.
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application filed May 27, 2011 for a novel topical Lidocaine Spray formulation (NRI-ANA), allowing for initiation of Phase 1 studies.
› Verified 7 days ago
| Entity Name | Melrosewakefield Healthcare, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841290467 PECOS PAC ID: 8224935838 Enrollment ID: O20040504000734 |
News Archive
Noting the United Nations on Wednesday observed the annual International Day of Zero Tolerance for Female Genital Mutilation and Cutting (FGM/C), "an act that is shocking and inhumane to much of the world but remains a tradition among a significant minority," Inter Press Service correspondent Marzieh Goudarzi interviews U.N. Population Fund (UNFPA) Executive Director Babatunde Osotimehin "on UNFPA's role in the global fight against FMG/C."
According to a recent study, led by Virginia Kaklamani, MD, an oncologist at Northwestern Memorial Hospital and assistant professor of medicine, Northwestern University Feinberg School of Medicine, variations of the adiponectin gene, which regulates a number of metabolic processes, may increase a woman's risk of developing breast cancer.
Meanwhile, news outlets report on a range of other implementation issues, including the decision of Ohio Gov. John Kasich to follow through on forming a state-based exchange despite his opposition to the overhaul, changes to FSAs and the measure's impact on farmers.
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application filed May 27, 2011 for a novel topical Lidocaine Spray formulation (NRI-ANA), allowing for initiation of Phase 1 studies.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David S Harnett, MD 170 Governors Ave, 1st Floor, Medford, MA 02155-1643 Ph: (781) 306-6160 | David S Harnett, MD 170 Governors Ave, 1st Floor, Medford, MA 02155-1643 Ph: (781) 306-6160 |
News Archive
Noting the United Nations on Wednesday observed the annual International Day of Zero Tolerance for Female Genital Mutilation and Cutting (FGM/C), "an act that is shocking and inhumane to much of the world but remains a tradition among a significant minority," Inter Press Service correspondent Marzieh Goudarzi interviews U.N. Population Fund (UNFPA) Executive Director Babatunde Osotimehin "on UNFPA's role in the global fight against FMG/C."
According to a recent study, led by Virginia Kaklamani, MD, an oncologist at Northwestern Memorial Hospital and assistant professor of medicine, Northwestern University Feinberg School of Medicine, variations of the adiponectin gene, which regulates a number of metabolic processes, may increase a woman's risk of developing breast cancer.
Meanwhile, news outlets report on a range of other implementation issues, including the decision of Ohio Gov. John Kasich to follow through on forming a state-based exchange despite his opposition to the overhaul, changes to FSAs and the measure's impact on farmers.
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application filed May 27, 2011 for a novel topical Lidocaine Spray formulation (NRI-ANA), allowing for initiation of Phase 1 studies.
› Verified 7 days ago
Michael L Glenn, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 26 Farragut Ave, Medford, MA 02155 Phone: 781-396-6424 | |
Samuel K Kelley, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 151 Mystic Ave Ste 6, C/o Judy Donnelly - Dcs Mental Healt, Medford, MA 02155 Phone: 617-877-8292 | |
Alicia M Azpiri Magallanes, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 26 City Hall Mall, Medford, MA 02155 Phone: 781-306-5463 Fax: 781-306-5015 | |
Dr. Alexis L Freedberg, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 170 Governors Ave, Lawrence Memorial Hospital, Medford, MA 02155 Phone: 781-306-6000 | |
Dr. Polihimnia B Cabaero, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 151 Mystic Ave, Suite # 6 Dcs Mental Health Inc., Medford, MA 02155 Phone: 718-396-1199 | |
Andrew M Aldridge, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 92 High St, Medford, MA 02155 Phone: 617-460-3611 Fax: 781-395-4571 |